Metagenomi, Other Current Liab from 2010 to 2024
| MGX Stock | 2.07 0.05 2.48% |
Other Current Liabilities | First Reported 2010-12-31 | Previous Quarter 10.9 M | Current Value 21 M | Quarterly Volatility 7 M |
Check Metagenomi, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Metagenomi, Common's main balance sheet or income statement drivers, such as Tax Provision of 9.7 M, Net Interest Income of 18.7 M or Interest Income of 18.7 M, as well as many indicators such as Price To Sales Ratio of 8.21, Dividend Yield of 0.0 or Days Sales Outstanding of 18.99. Metagenomi, financial statements analysis is a perfect complement when working with Metagenomi, Common Valuation or Volatility modules.
Metagenomi, | Other Current Liab |
Latest Metagenomi, Common's Other Current Liab Growth Pattern
Below is the plot of the Other Current Liab of Metagenomi, Common Stock over the last few years. It is Metagenomi, Common's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Metagenomi, Common's overall financial position and show how it may be relating to other accounts over time.
| Other Current Liab | 10 Years Trend |
|
Other Current Liab |
| Timeline |
Metagenomi, Other Current Liab Regression Statistics
| Arithmetic Mean | 22,792,518 | |
| Geometric Mean | 21,830,435 | |
| Coefficient Of Variation | 30.77 | |
| Mean Deviation | 3,254,105 | |
| Median | 23,131,000 | |
| Standard Deviation | 7,012,295 | |
| Sample Variance | 49.2T | |
| Range | 32.6M | |
| R-Value | (0.14) | |
| Mean Square Error | 51.9T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | (222,360) | |
| Total Sum of Squares | 688.4T |
Metagenomi, Other Current Liab History
About Metagenomi, Common Financial Statements
Metagenomi, Common investors use historical fundamental indicators, such as Metagenomi, Common's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Metagenomi, Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Current Liabilities | 10.9 M | 21 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Metagenomi, Stock Analysis
When running Metagenomi, Common's price analysis, check to measure Metagenomi, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi, Common is operating at the current time. Most of Metagenomi, Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi, Common's price. Additionally, you may evaluate how the addition of Metagenomi, Common to your portfolios can decrease your overall portfolio volatility.